Neurable
PrivateLast Round
Series A
Dec 19, 2025
Total Funding Raised
$61M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neurable operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series A round in December 2025.
Neurable is a neurotechnology company that develops AI-powered brain-computer interface (BCI) technology to translate neural activity into actionable insights for consumer devices.
Sector
Healthcare & Life Sciences
Verticals
Consumer Electronics, Mental Health, Medical Devices, Sensors
Business Model
B2B2C
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurable Comparables
Compare Neurable with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neurosity | 83% | |
| Vital Neuro | 83% | |
| IDUN Technologies | 82% |
For institutional investors. Book with your work email.
Neurable Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 19, 2025 | ||||
| Series A Extension | May 7, 2024 | ||||
| Series A | Dec 17, 2019 | ||||
| Seed | Aug 1, 2017 | ||||
| Seed | Dec 22, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Neurable Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pace Ventures | Series A, Series A Extension |
| Spectrum Moonshot Fund | Series A |
| PJC | Seed, Series A |
| Metaplanet Holdings | Series A Extension |
| M Ventures | Series A |
| Accomplice | Seed |
| U.S. Department of War | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 6, 2026
New partnership and product development revealed at CES 2026.
- Jan 6, 2026
Developing industry-first gaming headset with integrated neurotechnology with HyperX.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 7, 2026
Neurable launches the Brain Battery metric, which estimates remaining mental reserves and appears in the Neurable One brain-sensing headphones, for which U.S. preorders are open and orders ship in 4–8 weeks.
- launchesOct 1, 2026
On Oct 1st '26, Neurable launches its newest EEG-equipped brain-scanning headphones to monitor brainwaves while users work, rest, and play.
- launchesOct 1, 2026
Neurable Inc. launches Neurable One in Massachusetts
- launchesAug 12, 2026
Neurable develops smart headwear equipped with soft EEG sensors that record and interpret brain wave activity in real time, with linked AI software that can flag subtle deviations from a user’s baseline.
For institutional investors. Book with your work email.
Neurable Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neurable's valuation, stock price, and market status.
Is Neurable a public or private company?
Neurable is a private company.
What is the current stock price of Neurable?
Neurable is a private company, so its shares have no public market price. Caplight tracks Neurable's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neurable worth (valuation)?
Valuation information for Neurable is not publicly available.
Can I buy Neurable stock?
Neurable shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neurable's last funding round?
Neurable's most recent funding round was Series A on December 19, 2025.
Who are the main investors in Neurable?
Key investors in Neurable include Spectrum Moonshot Fund, M Ventures, Accomplice, Samuel Zell & Robert H. Lurie Institute for Entrepreneurship, Ultratech Capital Partners.
Will Neurable IPO soon?
No public IPO plans have been announced for Neurable.
How can I track Neurable secondary market activity?
Caplight tracks bids, offers, and trades in Neurable's shares on secondary markets.